Despite tremendous advances over the last decade, breast cancer remains the most common cancer affecting women globally, while recurrent resistance to existing therapies remains a major challenge. Leading cancer researchers … Continue reading University of Sussex and o2h Ventures Announce Creation and Investment in Oncology Drug Company Stingray Bio